ACH · Accendra Health Inc/Va/ · Webcasts, Transcripts & Audio
$0.49
-0.02 (-3.70%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$52.73M
Shares
76.90M
Volume · Oct 5
408.81K
Avg daily vol (3M)
1.34M
Accendra Health Inc Webcasts
Earnings calls, investor updates, investor days and conferences for Accendra Health Inc (ACH), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▼0.2%
$2.50B
$12.50M
'22 Q3
22-11-02
▲3.4%
$2.55B
−$57.99M
'22 Q4
23-02-28
▲4.8%
$2.52B
−$24.42M
'23 Q1
23-05-05
▲2.5%
$2.56B
−$28.24M
'23 Q2
23-08-04
▲3.8%
$2.59B
−$6.43M
'23 Q3
23-11-03
▼300.9%
$
$17.78M
'23 Q4
24-02-20
▲3.6%
$2.61B
−$21.89M
'24 Q1
24-05-03
▼74.2%
$660.40M
−$31.91M
'24 Q2
24-08-02
▼73.5%
$686.85M
−$12.77M
'24 Q3
24-11-04
·
$
−$296.12M
'24 Q4
25-02-28
▼74.2%
$673.88M
−$24.98M
'25 Q1
25-05-08
▲3.3%
$681.92M
−$869.06M
'25 Q2
25-08-11
▲1.5%
$697.26M
−$150.28M
'25 Q3
25-10-30
·
$708.97M
−$56.33M
'25 Q4
26-02-19
▼6.8%
$627.78M
−$6.47M
'26 Q1
26-05-11
LATEST
▼10.1%
$613.23M
−$89.07M
'26 Q2
26-08-10
Earnings call
FY26 · Q2
2026-08-10
Accendra Health Inc (ACH) Q2 2026 Earnings Call Transcript
Positive tone
Cost reduction and efficiency initiatives
CEO retirement and leadership transition
Sleep center of excellence rollout
Revenue
$613.23M
▼ 10.1% YoY Diluted EPS
$-1.16
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-11
Accendra Health Inc (ACH) Q1 2026 Earnings Call Transcript
Confident tone
Large commercial payor exit
Sleep therapy growth initiatives
Commercial payor portfolio and renewals
Revenue
$627.78M
▼ 6.8% YoY Diluted EPS
$-0.08
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-19
Accendra Health Inc (ACH) Q4 2025 Earnings Call Transcript
Confident tone
Loss of large commercial payer and stranded costs
Capital structure and debt reduction
Home-based care market opportunity
Revenue
$708.97M*
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-30
Accendra Health Inc (ACH) Q3 2025 Earnings Call Transcript
Confident tone
Loss of large customer (Kaiser) contract
Patient Direct home-based care strategy
Optum preferred provider agreement
Revenue
$697.26M
▲ 1.5% YoY Diluted EPS
$-1.94
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-11
Accendra Health Inc (ACH) Q2 2025 Earnings Call Transcript
Positive tone
Patient Direct strategic focus and divestiture of P&HS
Q2 financial results and revenue growth
Stranded costs and post-divestiture cost structure
Revenue
$681.92M
▲ 3.3% YoY Diluted EPS
$-11.30
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Accendra Health Inc (ACH) Q1 2025 Earnings Call Transcript
Positive tone
Patient Direct segment performance
Rotech acquisition
Medical Distribution and proprietary products
Revenue
$673.88M
▼ 74.2% YoY Diluted EPS
$-0.32
Gross margin
78.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-28
Accendra Health Inc (ACH) Q4 2024 Earnings Call Transcript
Positive tone
Patient Direct segment performance and growth
Rotech acquisition and regulatory clearance
Share repurchase program
Revenue
$*
Gross margin
-45.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-04
Accendra Health Inc (ACH) Q3 2024 Earnings Call Transcript
Confident tone
Patient Direct growth in sleep and diabetes
Rotech acquisition
Products and Healthcare Services segment performance
Revenue
$686.85M
▼ 73.5% YoY Diluted EPS
$-0.16
Gross margin
81.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-02
Accendra Health Inc (ACH) Q2 2024 Earnings Call Transcript
Confident tone
Patient Direct Segment Growth
Cash Flow and Working Capital
Products & Healthcare Services Segment Performance
Revenue
$660.40M
▼ 74.2% YoY Diluted EPS
$-0.42
Gross margin
82.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-03
Accendra Health Inc (ACH) Q1 2024 Earnings Call Transcript
Positive tone
Patient Direct segment performance and reimbursement
Free cash flow and balance sheet
Gross margin expansion
Revenue
$2.61B
▲ 3.6% YoY Diluted EPS
$-0.29
Gross margin
20.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-20
Accendra Health Inc (ACH) Q4 2023 Earnings Call Transcript
Confident tone
Patient Direct segment growth
2024 financial guidance
LIFO and stock comp normalization in adjusted EBITDA
Revenue
$*
▼ 300.9% YoY Gross margin
-11.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-03
Accendra Health Inc (ACH) Q3 2023 Earnings Call Transcript
Revenue
$2.59B
▲ 3.8% YoY Diluted EPS
$-0.08
▼ 150% YoY Gross margin
20.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-04
Accendra Health Inc (ACH) Q2 2023 Earnings Call Transcript
Revenue
$2.56B
▲ 2.5% YoY Diluted EPS
$-0.37
▼ 200% YoY Gross margin
20.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-05
Accendra Health Inc (ACH) Q1 2023 Earnings Call Transcript
Revenue
$2.52B
▲ 4.8% YoY Diluted EPS
$-0.32
▼ 161.5% YoY Gross margin
19.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-28
Accendra Health Inc (ACH) Q4 2022 Earnings Call Transcript
Revenue
$2.55B*
▲ 3.4% YoY Gross margin
16.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-02
Accendra Health Inc (ACH) Q3 2022 Earnings Call Transcript
Revenue
$2.50B
▼ 0.2% YoY Diluted EPS
$0.16
▼ 72.4% YoY Gross margin
20.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-03
Accendra Health Inc (ACH) Q2 2022 Earnings Call Transcript
Revenue
$2.50B
▲ 0.4% YoY Diluted EPS
$0.37
▼ 57.5% YoY Gross margin
21.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-03
Accendra Health Inc (ACH) Q1 2022 Earnings Call Transcript
Revenue
$2.41B
▲ 3.5% YoY Diluted EPS
$0.52
▼ 46.9% YoY Gross margin
15.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-23
Accendra Health Inc (ACH) Q4 2021 Earnings Call Transcript
Revenue
$2.47B*
▲ 4.5% YoY Gross margin
13.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-03
Accendra Health Inc (ACH) Q3 2021 Earnings Call Transcript
Revenue
$2.50B
▲ 14.4% YoY Diluted EPS
$0.58
▼ 23.7% YoY Gross margin
13.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-03
Accendra Health Inc (ACH) Q2 2021 Earnings Call Transcript
Revenue
$2.49B
▲ 37.7% YoY Diluted EPS
$0.87
Gross margin
16.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-05
Accendra Health Inc (ACH) Q1 2021 Earnings Call Transcript
Revenue
$2.33B
▲ 9.6% YoY Diluted EPS
$0.98
Gross margin
19.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-24
Accendra Health Inc (ACH) Q4 2020 Earnings Call Transcript
Revenue
$2.36B*
▲ 7.8% YoY Gross margin
16.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-02
Accendra Health Inc (ACH) Q3 2020 Earnings Call Transcript
Revenue
$2.19B
▼ 4.6% YoY Diluted EPS
$0.76
Gross margin
15.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-09-24
Accendra Health Inc (ACH) Q2 2020 Earnings Call Transcript
Revenue
$1.81B
▼ 23.9% YoY Diluted EPS
$-0.91
Gross margin
14.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-06
Accendra Health Inc (ACH) Q1 2020 Earnings Call Transcript
Revenue
$2.12B
▼ 9.7% YoY Gross margin
12.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-04
Accendra Health Inc (ACH) Q4 2019 Earnings Call
Revenue
$2.19B*
▲ 3.2% YoY Gross margin
13.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–27 of 27 webcasts